Why You Need Ensysce Biosciences Inc. (ENSC) On Your Watchlist

Ensysce Biosciences Inc. (NASDAQ:ENSC) saw a downside of -5.28% to close Friday at $2.87 after subtracting -$0.16 on the day. The 5-day average trading volume is 904,960 shares of the company’s common stock. It has gained $4.35 in the past week and touched a new high 1 time within the past 5 days. An average of 1,985,660 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 2,397,146.

ENSC’s 1-month performance is -7.72% or -$0.24 on its low of $2.81 reached on 10/01/21. The company’s shares have touched a 52-week low of $2.80 and high of $23.99, with the stock’s rally to the 52-week high happening on 02/01/21. YTD, ENSC has lost -76.92% or -$9.56 and has reached a new high 5 times. However, the current price is down -88.04%% from the 52-week high price.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Valuation Metrics

ENSC stock has a beta of -0.11. Moving on to other valuation ratios, the price-to-book (PB) in the most recent quarter is 9.57.

Ensysce Biosciences Inc.’s quick ratio for the recent quarter was 0.70, with the current ratio over the same period at 0.70 meaning that ENSC stock is able to fulfill its debt obligations. As well, the company’s total debt to equity was 0.26. The firm’s gross profit as reported stood at $5.92 million against revenue of $1.37 million.

The effectiveness of a company’s management is also important for investors when it comes to determining the potential profitability of the investment. Ensysce Biosciences Inc.’s return on assets over the past 12 months stands at 22.50%, while its return on equity (ROE) trailing 12 months is 107.10%. In comparison, the average ROE for the broader industry over the past year is -36.91.

Earnings Surprise

Net income grew 100.0% to $0.44 million, while revenue of $0.0 was 100.0% off the previous quarter. EBITDA for the quarter stood at more than -$0.41 million. ENSC stock balance sheet for the recent quarter shows that total liabilities totaled 4.03 million, with total debt at $0.48 million. Shareholders hold equity totaling $24.26 million

Technical Picture

Let’s look briefly at Ensysce Biosciences Inc. (ENSC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 01 October was 35.72% to suggest the stock is trending Neutral, with historical volatility in this time period at 243.54%.

The stock’s 5-day moving average is $3.31, reflecting a -36.08% or -$1.62 change from its current price. ENSC is currently trading -9.69% above its 20-day SMA, -77.87% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -59.00% and -72.67% respectively.

Stochastic %K and %D was 4.54% and 12.75% and the average true range (ATR) pointed at 0.59. The RSI (14) points at 38.18%, while the 14-day stochastic is at 2.17% with the period’s ATR at 0.60. The stock’s 9-day MACD Oscillator is pointing at -0.82 and -0.54 on the 14-day charts.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam